Would Harvey, Sulston, and Darwin Get Funded Today?

At a recent meeting of a National Institutes of Health study section, a colleague dismissed a proposal as "descriptive." In study-sectionese, this is essentially the kiss of death. Several aspects about this attitude trouble me. The first is the proposition that the word descriptive is synonymous with bad. Perhaps I am being a hopeless 19th century romantic, but it appears to me that some of the most important contributions in the history of biomedical sciences have come from what would now be

Written byTv Rajan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

At a recent meeting of a National Institutes of Health study section, a colleague dismissed a proposal as "descriptive." In study-sectionese, this is essentially the kiss of death. Several aspects about this attitude trouble me.

The first is the proposition that the word descriptive is synonymous with bad. Perhaps I am being a hopeless 19th century romantic, but it appears to me that some of the most important contributions in the history of biomedical sciences have come from what would now be dismissed as descriptive. Whether it is William Harvey's description of the circulation of blood or J.E. Sulston's incomparably lovely cell lineage tree in Caenorhabditis elegans, our science is primarily driven by careful observation and painstaking description.

Similarly, Baruch Blumberg made a seminal contribution to our understanding of biology when he discovered the etiological agent of hepatitis B. His studies were not directed toward this goal or at documenting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies